Latest filing published 20 Jun 2024 for Pacific Biosciences of California, INC..
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -71.0%Entry US$4.59 · Close at T+365 US$1.33
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
David W. Meline: trading record in brief
This profile gathers the share dealings of David W. Meline across 6 companies, led by 3M Co, Amgen Inc and Moderna, Inc. In total, 79 filings cover trades dated from 9 February 2009 to 18 June 2024.
On the open market, the record shows 1 purchase worth €162k and 10 sales worth €3.5M. The net balance comes to €3.3M on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 45 share grants and 14 option exercises. 2024 to date brings 1 purchase and no sales.
Most recently, on 20 June 2024, the filings show a share grant in Pacific Biosciences of California, Inc. The latest purchase dates back some time: it was published 978 days ago, on 6 March 2024. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to David W. Meline
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 17,116 shares0Common StockSEC:0001299130-24-000151:0
- 7,943 shares0Common StockSEC:0000950172-24-000228:0
- 40,000 shares@ US$4.404100.0% of flowCommon StockSEC:0001299130-24-000076:0Canonical exit: 4 Jun 2024 (T+90)
- 2,747 shares0Common StockSEC:0001209191-23-054388:0
- 164 shares@ US$173.6615.5% of flowCommon StockSEC:0001127602-22-020829:1
- 348 shares0Common StockSEC:0001127602-22-020829:0
- 156 shares@ US$133.7111.1% of flowCommon StockSEC:0001127602-22-014148:1
- 348 shares@ US$134.40100.0% of flowCommon StockSEC:0001127602-22-014148:0
- 619 shares@ US$158.8948.4% of flowCommon StockSEC:0001127602-22-004566:1
- 1,392 shares0Common StockSEC:0001127602-22-004566:0
- 8,737 shares@ US$234.3638.8% of flowCommon StockSEC:0001127602-19-033709:0
- 4,511 shares0Common StockSEC:0001127602-19-017650:1
- 795 shares@ US$176.502.6% of flowCommon StockSEC:0001127602-19-017650:0
- 746 shares@ US$179.322.4% of flowCommon StockSEC:0001127602-19-017343:0
- 8,040 shares@ US$191.8927.2% of flowCommon StockSEC:0001127602-19-013162:0
- 16,086 shares0Common StockSEC:0001127602-19-010656:0
- 528 shares@ US$192.111.8% of flowCommon StockSEC:0001127602-19-003508:0
- 7,382 shares@ US$196.5520.5% of flowCommon StockSEC:0001127602-18-024508:0
- 773 shares@ US$169.431.3% of flowCommon StockSEC:0001127602-18-016537:0
- 4,508 shares0Common StockSEC:0001127602-18-015841:0
- 7,549 shares@ US$176.0813.0% of flowCommon StockSEC:0001127602-18-012859:0
- 15,118 shares0Common StockSEC:0001127602-18-011022:0
- 496 shares@ US$198.001.0% of flowCommon StockSEC:0001127602-18-003051:0
- 7,562 shares@ US$174.5113.5% of flowCommon StockSEC:0001127602-17-024641:0
- 4,305 shares0Common StockSEC:0001127602-17-016755:0
25 of 76 declarations
